MDCX Medicus Pharma Ltd.: institutional ownership and insider trading
22 funds reported holding $1.17M of Medicus Pharma Ltd. in their latest 13F filings; in Q2 2026 funds net bought $135K, with 9 new positions and 7 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
MDCX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$11.6M, EPS -0.21
- Quarter ended Mar 31, 2026: revenue n/a, net income −$9.04M, EPS -0.31
- Quarter ended Dec 31, 2025: revenue n/a, net income −$15.1M, EPS -0.77
- Quarter ended Sep 30, 2025: revenue n/a, net income −$20.9M, EPS -1.12
Famous investors holding MDCX
- Ken Griffin (Citadel Advisors): $11.2K, 0.0% of the portfolio
Largest institutional holders of MDCX
- Interchange Capital Partners, LLC — $718K
- JANE STREET GROUP, LLC — $149K
- XTX Topco Ltd — $109K
- Sterling Investment Advisors, Ltd. — $44.6K
- COMMONWEALTH EQUITY SERVICES, LLC — $23.5K
- May Hill Capital, LLC — $22.6K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $14.0K
- STIFEL FINANCIAL CORP (SF, SFB, SF-PB, SF-PC, SF-PD) — $13.4K
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $12.5K
- CITADEL ADVISORS LLC — $11.2K
Recent MDCX insider trades
- May 20, 2025: Velocity Fund Partners, Lp sold 75,000 shares ($579K)
5%+ owners
- BOKHARI, RAZA: 5.3% (Schedule 13D, filed Sep 14, 2026)